@inproceedings{inproceedings, title  = {{Ixazomib, Thalidomide and Dexamethasone Is an Effective and Well Tolerated Re-Induction Regimen Leading to Salvage Autologous Stem Cell Transplantation (sASCT): Results from the Re-Induction Interim Analysis of UK-MRA Myeloma XII (ACCoRD) Trial}},

 publisher = {{American Society of Hematology}},

 url = {{}},

 year = {{2018}},

 month = {{11}},

 author = {{Cook G and Parrish C and Yong K and Cavenagh J and Snowden JA and Drayson MT and Garg M and Cairns D and Ashcroft J and Striha A and Hockaday A et al}},

 doi = {{10.1182/blood-2018-99-112116}},

 volume = {{132}},

 journal = {{Blood}},

 issue = {{Supplement 1}},

 pages = {{255-255}},

 note = {{Accessed on 2024/12/22}}}